These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1295 related items for PubMed ID: 9886762

  • 1. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [Abstract] [Full Text] [Related]

  • 2. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
    Pickavance L, Widdowson PS, King P, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Oct; 125(4):767-70. PubMed ID: 9831913
    [Abstract] [Full Text] [Related]

  • 3. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E, Stocker C, Augstein P, Heinke P, Meyer A, Hoffmann T, Subramanian A, Sennitt MV, Demuth HU, Arch JR, Cawthorne MA.
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
    Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ.
    Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
    [Abstract] [Full Text] [Related]

  • 5. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
    Goh TT, Mason TM, Gupta N, So A, Lam TK, Lam L, Lewis GF, Mari A, Giacca A.
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
    [Abstract] [Full Text] [Related]

  • 6. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y, Donahue EP, Shiota M.
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [Abstract] [Full Text] [Related]

  • 7. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM, Risovic V, Yuen VG, McNeill JH.
    J Trace Elem Med Biol; 2006 Sep; 19(4):251-8. PubMed ID: 16443173
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F, Abdallah P, Basset A, del Carmine P, Haffar G, Beylot M.
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [Abstract] [Full Text] [Related]

  • 9. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y, Shimura Y, Ikeda H.
    Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
    [Abstract] [Full Text] [Related]

  • 10. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone.
    Nadeau KJ, Ehlers LB, Aguirre LE, Reusch JE, Draznin B.
    Diabetes Obes Metab; 2007 Sep; 9(5):714-23. PubMed ID: 17697064
    [Abstract] [Full Text] [Related]

  • 11. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H, Takeshita S, Yamamoto T, Mabuchi M, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Ita M, Mutoh S.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):182-90. PubMed ID: 16039648
    [Abstract] [Full Text] [Related]

  • 12. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD.
    Am J Physiol Endocrinol Metab; 2003 May 05; 284(5):E892-900. PubMed ID: 12517738
    [Abstract] [Full Text] [Related]

  • 13. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
    Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M.
    Obesity (Silver Spring); 2008 Sep 05; 16(9):2081-7. PubMed ID: 18551111
    [Abstract] [Full Text] [Related]

  • 14. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
    Clerk LH, Vincent MA, Barrett EJ, Lankford MF, Lindner JR.
    Am J Physiol Endocrinol Metab; 2007 Dec 05; 293(6):E1804-9. PubMed ID: 17911341
    [Abstract] [Full Text] [Related]

  • 15. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
    Dokken BB, Henriksen EJ.
    Am J Physiol Endocrinol Metab; 2006 Aug 05; 291(2):E207-13. PubMed ID: 16478771
    [Abstract] [Full Text] [Related]

  • 16. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T.
    Arzneimittelforschung; 1990 Feb 05; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [Abstract] [Full Text] [Related]

  • 17. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
    Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ, Herrero P.
    J Nucl Med; 2006 Apr 05; 47(4):689-97. PubMed ID: 16595504
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
    George C, Lochner A, Huisamen B.
    J Ethnopharmacol; 2011 Sep 01; 137(1):298-304. PubMed ID: 21645608
    [Abstract] [Full Text] [Related]

  • 19. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T, Jazbutyte V, Arias-Loza PA, Segerer S, Lichtenwald M, Law MP, Schäfers M, Ertl G, Neyses L.
    Biochem Biophys Res Commun; 2005 Apr 08; 329(2):726-32. PubMed ID: 15737646
    [Abstract] [Full Text] [Related]

  • 20. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
    Chirieac DV, Collins HL, Cianci J, Sparks JD, Sparks CE.
    Am J Physiol Endocrinol Metab; 2004 Jul 08; 287(1):E42-9. PubMed ID: 14970003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.